图像分析技术结合超声造影在内生型肾肿瘤剜除术中的应用研究
摘要
<正>随着诊疗水平的提高,近年来,肾肿瘤剜除术已广泛用于内生型肾肿瘤治疗。由于该方法保留了患肾,是否更容易导致肿瘤的残留、复发和转移引起广泛关注。内生型小肿瘤由于边界难辨,质地不易区分等因素,肿瘤的形态、浸润及安全切缘成为讨论的热点。笔者所在科采用术中超声造影结合图
引文
[1]燕翠菊,黄备建,王文平,等.肾良恶性占位超声造影定量参数分析的初步研究[J].中华超声影像学杂志,2012,21(4):312-315.
[2]康素海,叶慧义. MRI、B超及超声造影诊断小肾肿瘤的现状及进展[J].中国医学影像学杂志,2016,24(5):396-399.
[3] HUANG WC,LEVEY AS,SERIO AM,et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours:a retrospective cohort study[J]. Lancet Oncol,2006,7(9):735-740.
[4] DAUGHERTY M,BRATSLAVSKY G. Compared with radical nephrectomy,nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas(≤4 cm):an analysis of the SEER databas[J]. Urol Oncol,2014,32(5):549-554.
[5] TAN HI,NORTON EC,YE Z,et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer[J]. JAMA,2012,307(15):1629-1635.
[6] MACLENNAN S,IMAMURA M,LAPITAN MC,et al. Systematic review of oncological outcomes following surgical management of localised renal cancer[J]. Eur Urol,2012,61(5):972-993.
[7] UZZO RG,NOVICK AC. Nephron sparing surgery for renal tumors:indications,techniques and outcomes[J]. J Urol,2001,166(1):6-18.
[8] LASSAU N,CHEBIL M,CHAMI L,et al. Dynamic contrastenhanced ultrasonography(DCE-US):a new tool for the early evaluation of antiangiogenic treatment[J]. Target Oncol,2010,5(1):53-58.
[9] ZHANG YH,YANG Q,CUI W,et al. Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma[J]. Zhonghua ZhongLiu ZaZhi,2010,32(2):117-122.
[10]刘学会,聂芳.超声造影在肾脏疾病中的应用及前景[J].国际医学放射学杂志,2014,37(6):556-559.
[11] JIANG J,CHEN Y,ZHOU Y,et al. Clear cell renal cell carcinoma:contrast-enhanced ultrasound features relation to tumor size[J]. Eur J Radiol,2010,73(1):162-167.
[12] BERNHARD JC,PANTUCK AJ,WALLERAND H,et al. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma[J]. Eur Urol,2010,57(6):1080-1086.
[13] SPIRINA LV,YUNUSOVA NV,KONDAKOVA IV,et al. Association of growth factors,HIF-1 and NF-kB expression with proteasomes in endometrial cancer[J]. Mol Biol Rep,2012,39(9):8655-8662.
[14]沈瑞雄,白培明,苏汉忠,等. T1期肾细胞癌保留肾单位手术安全切除边距的研究[J].医学与哲学,2014,35(12):44-52.
[2]康素海,叶慧义. MRI、B超及超声造影诊断小肾肿瘤的现状及进展[J].中国医学影像学杂志,2016,24(5):396-399.
[3] HUANG WC,LEVEY AS,SERIO AM,et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours:a retrospective cohort study[J]. Lancet Oncol,2006,7(9):735-740.
[4] DAUGHERTY M,BRATSLAVSKY G. Compared with radical nephrectomy,nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas(≤4 cm):an analysis of the SEER databas[J]. Urol Oncol,2014,32(5):549-554.
[5] TAN HI,NORTON EC,YE Z,et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer[J]. JAMA,2012,307(15):1629-1635.
[6] MACLENNAN S,IMAMURA M,LAPITAN MC,et al. Systematic review of oncological outcomes following surgical management of localised renal cancer[J]. Eur Urol,2012,61(5):972-993.
[7] UZZO RG,NOVICK AC. Nephron sparing surgery for renal tumors:indications,techniques and outcomes[J]. J Urol,2001,166(1):6-18.
[8] LASSAU N,CHEBIL M,CHAMI L,et al. Dynamic contrastenhanced ultrasonography(DCE-US):a new tool for the early evaluation of antiangiogenic treatment[J]. Target Oncol,2010,5(1):53-58.
[9] ZHANG YH,YANG Q,CUI W,et al. Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma[J]. Zhonghua ZhongLiu ZaZhi,2010,32(2):117-122.
[10]刘学会,聂芳.超声造影在肾脏疾病中的应用及前景[J].国际医学放射学杂志,2014,37(6):556-559.
[11] JIANG J,CHEN Y,ZHOU Y,et al. Clear cell renal cell carcinoma:contrast-enhanced ultrasound features relation to tumor size[J]. Eur J Radiol,2010,73(1):162-167.
[12] BERNHARD JC,PANTUCK AJ,WALLERAND H,et al. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma[J]. Eur Urol,2010,57(6):1080-1086.
[13] SPIRINA LV,YUNUSOVA NV,KONDAKOVA IV,et al. Association of growth factors,HIF-1 and NF-kB expression with proteasomes in endometrial cancer[J]. Mol Biol Rep,2012,39(9):8655-8662.
[14]沈瑞雄,白培明,苏汉忠,等. T1期肾细胞癌保留肾单位手术安全切除边距的研究[J].医学与哲学,2014,35(12):44-52.